Impact of gemtuzumab ozogamicin on MRD and relapse risk in patients with NPM1-mutated AML: results from the AMLSG 09-09 trial

Kapp-Schwoerer, Silke; Weber, Daniela; Corbacioglu, Andrea; Gaidzik, I, Verena; Paschka, Peter; Krönke, Jan; Theis, Frauke; Rücker, Frank G.; Teleanu, Maria-Veronica; Panina, Ekaterina; Jahn, Nikolaus; Herzig, Julia; Kubanek, Lena; Schrade, Anika; Goehring, Gudrun; Fiedler, Walter; Kindler, Thomas; Schroeder, Thomas; Mayer, Karin T.; Lübbert, Michael; Wattad, Mohammed; Götze, Katherina S.; Horst, Heinz A.; Koller, Elisabeth; Wulf, Gerald; Schleicher, Jan; Bentz, Martin; Kreuter, Jürgen; Bullinger, Lars; Krzykalla, Julia; Benner, Axel; Schlenk, Richard Friedrich; Thol, Felicitas; Heuser, Michael; Ganser, Arnold; Döhner, Hartmut; Döhner, Konstanze

Erstveröffentlichung

2020

Metadata only
Search for full text

Wissenschaftlicher Artikel

Authors

Kapp-Schwoerer, Silke

Weber, Daniela

Corbacioglu, Andrea

Gaidzik, I, Verena

Paschka, Peter

et al.

Institutions

UKU. Klinik für Innere Medizin III

Published in

Blood ; 136 (2020), 26. - S. 3041-3050. - ISSN 0006-4971. - eISSN 1528-0020

Link to publication

https://dx.doi.org/10.1182/blood.2020005998

Keywords

ACUTE MYELOID-LEUKEMIA; MINIMAL RESIDUAL DISEASE; POLYMERASE-CHAIN-REACTION; PROGNOSTIC-SIGNIFICANCE; NPM1; MUTATIONS; CLASSIFICATION; NUCLEOPHOSMIN; DIAGNOSIS

Dewey Decimal Group

DDC 610 / Medicine & health

Metadata

Show full item record